STOCK TITAN

Lipocine Inc - LPCN STOCK NEWS

Welcome to our dedicated news page for Lipocine (Ticker: LPCN), a resource for investors and traders seeking the latest updates and insights on Lipocine.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Lipocine's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Lipocine's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.38%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.25%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.06%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.78%
Tags
conferences clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.83%
Tags
clinical trial
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.31%
Tags
none
-
Rhea-AI Summary
Lipocine Inc. announces selection of three abstracts for poster presentations at The Liver Meeting 2021
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.92%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.42%
Tags
none
Lipocine Inc

Nasdaq:LPCN

LPCN Rankings

LPCN Stock Data

27.64M
5.16M
3.03%
9.17%
2.33%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Salt Lake City

About LPCN

lipocine inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. the company develops drugs based on hydroance, a drug delivery technology. it primarily focuses on developing oral versions of several hormones for use in men and women health. the company’s lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. it also offers custom drugs for pharmaceutical/biotechnology companies. lipocine inc. was founded in 1997 and is headquartered in salt lake city, utah.